Updated:
Menadiona
MENADIONA is a leading player in manufacturing AZIRIDINE (ethylene imine) and AZIRIDINE DERIVATES (propylenen imine). The extensive expertise in handling such...
Menadiona
MENADIONA is a leading player in manufacturing AZIRIDINE (ethylene imine) and AZIRIDINE DERIVATES (propylenen imine). The extensive expertise in handling such hazardous materials enables us to offer the most comprehensive service.
General information
Firm type
Corporate Investor
Year founded
1970
AUM
Undisclosed
Location
Region
Europe
Country
Spain
City
Palafolls
Corporate office
Pol. Ind. Mas Puigvert, s/n, 08389 Palafolls, Barcelona, Spain
Additional offices
Málaga, Spain
Principals
Carlos Cosin
CEO and President
Sector focus
Frequently asked questions
Who runs investment decisions at Menadiona?
Investment decisions sit with CEO Carlos Cosin and the board, now including Portobello Capital representatives after the 2024 majority acquisition. The firm does not employ a dedicated CIO or formal investment committee structure typical of standalone family offices.
Is Menadiona structured as a single family office?
No. Menadiona is a corporate investor — an operating chemical manufacturer that invests off its balance sheet. The Cosin family sold a majority stake to Portobello Capital in 2024, ending exclusive family control while retaining the company as the investment vehicle.
How does Menadiona source deals?
Deal flow originates from the firm's industrial network in specialty chemicals, life sciences, and manufacturing. Menadiona co-invests alongside external venture investors, as seen in the Roka Furadada Series A round with O Financial Club and Women Angels for Steam, rather than leading rounds independently.
Does Menadiona accept outside capital?
Not directly. Menadiona is not an asset manager open to third-party commitments. External investors can co-invest alongside Menadiona in specific deals, and Portobello Capital holds the majority stake, but there is no open fund vehicle.
Which sectors does Menadiona target for investment?
Investments follow the firm's operational expertise: pharmaceutical APIs and intermediates, performance chemicals for coatings and adhesives, and contract manufacturing technologies. The Roka Furadada investment extends this into advanced materials for sun protection.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on asset managers?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: